What sectors does EcoR1 Capital invest in?

San Francisco-based biotech specialist with $5B+ AUM, investing in small and mid-cap listed biotechnology companies as well as private venture rounds. Founded by Oleg Nodelman in 2012.

Typical check size

€10M – €100M

Fund size: $5B+ AUM; biotech-focused hedge fund and venture investor; founded 2012

Browse similar check sizes →

Portfolio highlights

Zymeworks - bispecific antibody and ADC platform (NASDAQ-listed)

AnaptysBio - antibody discovery for inflammation (NASDAQ-listed)

Jazz Pharmaceuticals - neuroscience and oncology (NASDAQ-listed)

Contact

www.ecor1cap.com

United States

Research with AI

Learn more about EcoR1 Capital using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what EcoR1 Capital and similar investors look for:

Biotech pitch guide

Ready to start fundraising?

Create your pitch deck with AI, get investor-ready feedback, and find the right investors for your startup.

Get started free

Venture capital

United States

EcoR1 Capital

Investment focus

Sectors

Biotech

Investment stages

Series A

Series B

Growth

Geographic focus

Global

United States

Investment thesis

San Francisco-based biotech specialist with $5B+ AUM, investing in small and mid-cap listed biotechnology companies as well as private venture rounds. Founded by Oleg Nodelman in 2012.